Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
life sciences
national blog main
national top stories
new york blog main
new york top stories
san diego blog main
san diego top stories
3
×
san francisco blog main
san francisco top stories
boulder/denver blog main
boulder/denver top stories
clinical trials
detroit blog main
detroit top stories
gilead sciences
indiana blog main
indiana top stories
national
raleigh-durham blog main
raleigh-durham top stories
sanofi
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
alector
alirocumab
alkermes
allergan
amgen
avrobio
baricitinib
bcma
biotech
bolt biotherapeutics
bristol-myers squibb
What
known
3
×
new
3
×
drug
approved
bio
biopharma
cholesterol
congress
congressional
crispr
data
disease
drugs
executives
expensive
faces
fatty
feud
financial
foe
group
healthcare
hint
horizon
inhibitors
intercept
isn’t
later
liver
lowering
marketed
medicine
month
nash
nonalcoholic
ny
pcsk
pharma
remember
roster
Language
unset
Current search:
known
×
new
×
" san diego top stories "
×
@xconomy.com
4 years ago
New PCSK9 Cholesterol Drug Faces Tough Foe. (Hint: Not Cholesterol.)
@xconomy.com
5 years ago
With New Data, Intercept On Track for First-Ever Approved NASH Drug
@xconomy.com
5 years ago
Bio Roundup: New CRISPR Feud, A NY Splash, Pharma vs. Congress & More